Polee, M B <br/><br/>
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Jul 2002 
 - 1495-500 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(02)00081-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Diarrhea--chemically induced<br/>Dose-Response Relationship, Drug<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Nervous System Diseases--chemically induced<br/>Paclitaxel--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome